Bone Biologics Corp (BBLG)
2.19
+0.15
(+7.35%)
USD |
NASDAQ |
Mar 28, 16:00
2.19
0.00 (0.00%)
After-Hours: 16:09
Bone Biologics Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2021 | 7.904M |
September 30, 2021 | 1.168M |
June 30, 2021 | 0.9663M |
March 31, 2021 | 0.4738M |
December 31, 2020 | 0.4028M |
September 30, 2020 | 0.3996M |
June 30, 2020 | 0.8249M |
March 31, 2020 | 1.748M |
December 31, 2019 | 2.32M |
September 30, 2019 | 2.20M |
June 30, 2019 | 4.97M |
March 31, 2019 | 4.57M |
December 31, 2018 | 4.37M |
Date | Value |
---|---|
September 30, 2018 | 4.37M |
June 30, 2018 | 2.50M |
March 31, 2018 | 1.90M |
December 31, 2017 | 3.40M |
September 30, 2017 | 4.60M |
June 30, 2017 | 3.20M |
March 31, 2017 | 3.20M |
December 31, 2016 | 6.833M |
September 30, 2016 | 5.633M |
June 30, 2016 | 5.633M |
March 31, 2016 | 7.633M |
December 31, 2015 | 2.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.3996M
Minimum
Sep 2020
7.904M
Maximum
Dec 2021
2.329M
Average
1.458M
Median
Cash from Financing (TTM) Benchmarks
Cingulate Inc | 9.050M |
Microbot Medical Inc | -- |
First Wave BioPharma Inc | 16.39M |
Cytokinetics Inc | 221.32M |
Calidi Biotherapeutics Inc | -- |